Your browser doesn't support javascript.
loading
Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in high risk diffuse large cell B-cell lymphoma patients as a first line treatment.
Schwarzbich, Mark-Alexander; Schöning, Tilman; Cremer, Martin; Lisenko, Katharina; Ho, Anthony D; Witzens-Harig, Matthias.
Affiliation
  • Schwarzbich MA; a Department of Hematology and Oncology , University Hospital Heidelberg , Heidelberg , Germany ;
  • Schöning T; b Department of Pharmacy , University Hospital Heidelberg , Heidelberg , Germany.
  • Cremer M; a Department of Hematology and Oncology , University Hospital Heidelberg , Heidelberg , Germany ;
  • Lisenko K; a Department of Hematology and Oncology , University Hospital Heidelberg , Heidelberg , Germany ;
  • Ho AD; a Department of Hematology and Oncology , University Hospital Heidelberg , Heidelberg , Germany ;
  • Witzens-Harig M; a Department of Hematology and Oncology , University Hospital Heidelberg , Heidelberg , Germany ;
Leuk Lymphoma ; 57(7): 1723-6, 2016 07.
Article in En | MEDLINE | ID: mdl-26980422

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Large B-Cell, Diffuse Type of study: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2016 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Large B-Cell, Diffuse Type of study: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2016 Document type: Article